Estrogen response element binding proteins and nucleotides encoding therefor
CA 2245806 A1 · Owner: Cedars-Sinai Medical Center · Inventors: Adams, John S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the discovery and purification of novel estrogen response element binding proteins. Estrogen response element binding proteins are distinct from the estrogen receptor and other intracellular receptors e.g. estrogen receptor. Estrogen response element binding proteins can interfere with the biological activity of the estrogen receptor and other related intracellular receptor proteins. One aspect of the invention is to provide purified estrogen response element binding proteins. Another aspect of the invention is to provide antibodies capable of binding to the estrogen response element binding proteins of the invention. Another aspect of the invention is to …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 12, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 12, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 12, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.